Pillstats
Rx only · Tablet, Film Coated · Oral

Estradiol And Norethindrone Acetate

Brands: Estradiol / Norethindrone Acetate · Etyqa · Mimvey · Estradiol + Norethindrone Acetate

4 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US6 NDCs
4 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)7514
US makers4 labelers
Packages9
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 4 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.224$0.448$0.672$0.896Dec 2025Apr 2026Jul 2026
$0.724
Latest avg · Jul 22, 2026
-7%
Since Dec 17, 2025
4
Active US suppliers
67%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

9151.8K2.7K3.7K2025 Q12025 Q22025 Q32025 Q42026 Q1
2.5K
Rx · 2026 Q1
93K
Units dispensed
-20%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it4 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Aurobindo Pharma Limitedunknown4SUPPLYING
Teva Pharmaceuticals USA, Inc.unknown2SUPPLYING
Breckenridge Pharmaceutical, Inc.unknown2SUPPLYING
A-S Medication Solutionsunknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Jan 7, 2022
    RECALLRecall (Class III): Mimvey (estradiol and norethindrone acetate tablets USP), 1 mg/0.5 mg, packaged in cartons of 28 Tablets, Rx only, Manu…

    Mislabeling — Recalling firm: Teva Pharmaceuticals USA — USA Nationwide

  • Jan 7, 2022
    RECALLRecall (Class III): Mimvey (estradiol and norethindrone acetate tablets USP) 1 mg/0.5 mg, packaged in cartons of 28 Tablets, Rx Only, Manuf…

    Mislabeling — Recalling firm: Teva Pharmaceuticals USA — USA Nationwide